Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.
about
The gastric HK-ATPase: structure, function, and inhibitionPotassium Channelopathies and Gastrointestinal UlcerationLong lasting inhibitors of the gastric H,K-ATPaseClinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects.Pharmacokinetics, pharmacodynamics and safety of febuxostat, a non-purine selective inhibitor of xanthine oxidase, in a dose escalation study in healthy subjects.Review article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.Developments in the inhibition of gastric acid secretion.Role of potassium in acid secretionPharmacological targets in gastro-oesophageal reflux disease.Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis.Emerging drugs for gastroesophageal reflux disease.Revisiting the parietal cell.Current pharmacological management of gastroesophageal reflux disease.Mitigating endoplasmic reticulum stress with revaprazan ameliorates stress-related mucosal disease.Characteristics of the K+-competitive H+,K+-ATPase inhibitor AZD0865 in isolated rat gastric glands.A matched case-control study of a novel Acid-pump antagonist and proton-pump inhibitor for the treatment of iatrogenic ulcers caused by endoscopic submucosal dissection.Synthesis and Antiulcer Activity Studies of 2-(1'-Iminothioimido Substituted)-1'-Substituted Phenylbenzoic acids.In vitro and in vivo protection against indomethacin-induced small intestinal injury by proton pump inhibitors, acid pump antagonists, or indomethacin-phosphatidylcholine.A novel K+ competitive acid blocker, YH4808, sustains inhibition of gastric acid secretion with a faster onset than esomeprazole: randomised clinical study in healthy volunteers.Vonoprazan fumarate, a novel potassium-competitive acid blocker, in the management of gastroesophageal reflux disease: safety and clinical evidence to date.Recent Advances in the Pharmacological Management of Gastroesophageal Reflux Disease.Simultaneous engineering of an enzyme's entrance tunnel and active site: the case of monoamine oxidase MAO-N
P2860
Q24612375-9BB36BC9-9D34-434E-AED4-ED1369D075F2Q28072892-37F740AB-A3A6-480C-B90A-D457C81AD473Q28299927-8897163C-FD44-4213-82C9-31C31CC8E4DCQ34140776-19947928-1316-463D-9E7D-F6CF8BD22C25Q34569581-3298CA87-4827-46BD-918E-AA46BF885CA4Q35772657-99D75093-12A9-42FF-A681-73E8A485EE4EQ36230670-0B09A036-1631-4E87-B488-08216C8C0FD6Q36252012-BA3B4F4D-E598-4B2B-9F3B-DE1BEE8283D2Q36346427-5191C9D1-5608-462D-9292-9CF5192490A4Q37238180-9B889535-F3C6-487E-A335-A28791F5AF9DQ37570546-37F72938-5010-4615-8A11-A477DD727DF5Q37627474-2C3CC5BC-0EF1-4FAA-B419-B5580C7C54D6Q38123482-9BD7E704-B82F-43C7-8029-DA6068FA4290Q39514546-90A6ADCD-BC35-4C37-96C3-12C2969092D2Q39760161-D49744C4-ACB6-4E85-87E2-7414A36845F0Q40606354-96AFA521-4601-4F40-947E-C2C2B1056C28Q42128483-8521C4E8-F4F5-4AED-B58E-A7BEAA209551Q42410644-65809CBE-FB15-4495-BEE9-C0187ABB0081Q48099127-E093AD79-A4E7-40CF-80CC-961F5DAD3C1AQ49447901-DC55057A-3B0F-4B8B-8EF9-32F5267324AEQ50129556-35EE5832-E26F-4D78-970E-C26972516263Q56891246-5DE05746-12CD-400E-99D0-A45557A4B815
P2860
Pharmacokinetic and pharmacodynamic evaluation of a novel proton pump inhibitor, YH1885, in healthy volunteers.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@ast
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@en
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@nl
type
label
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@ast
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@en
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@nl
prefLabel
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@ast
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@en
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers.
@nl
P2093
P2860
P356
P1476
Pharmacokinetic and pharmacody ...... YH1885, in healthy volunteers
@en
P2093
Byoung-Seok Moon
Hyeong-Seok Lim
In-Jin Jang
Jae-Yong Chung
Ji-Hong Shon
Joo-Youn Cho
Keun-Seog Song
Kyung-Sang Yu
Sang-Goo Shin
So-Young Yi
P2860
P356
10.1177/0091270003261321
P577
2004-01-01T00:00:00Z